RBD4059
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RBD4059, covering 2024-12-03 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease [Phase 2]